Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (11-20 of 392) with videos related to

Pageof 40
Sort By:
Cell Cycle (Georgetown, Tex.)|June 23, 2005
TELAML1-positive ALL: a discordant genotypeMonique L den Boer, William E Evans, Rob Pieters
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2006
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginasesInge M Appel, Wim C J Hop, Rob Pieters
Seminars in Fetal & Neonatal Medicine|April 19, 2012
Diagnosis and management of neonatal leukaemiaMarieke H van der Linden, Sara Creemers, Rob Pieters
British Journal of Haematology|February 1, 2006
Towards targeted therapy for infant acute lymphoblastic leukaemiaRonald W Stam, Monique L den Boer, Rob Pieters
Pediatric Blood & Cancer|April 5, 2008
Perceived and actual motor competence of children treated for cancer with vincristine containing chemotherapyAnnelies Hartman, Rob Pieters, Cor van den Bos, et al.
Pediatric Blood & Cancer|September 24, 2015
Ammonia Levels Should Not Be Used as a Surrogate Marker of Levels of Asparaginase Activity in Acute Lymphoblastic Leukemia PatientsWing H Tong, Rob Pieters, Inge M van der Sluis
Pediatric Blood & Cancer|September 1, 2007
Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancerAnnelies Hartman, Cor van den Bos, Theo Stijnen, et al.
Cancer|February 3, 2006
Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristineAnnelies Hartman, Cor van den Bos, Theo Stijnen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic reviewLeiah J Brigitha, Rob Pieters, Inge M van der Sluis
Haematologica|June 3, 2016
HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?Jules Pp Meijerink, Kirsten Canté-Barrett, Eric Vroegindeweij, et al.
Pageof 40

Showing results (11-20 of 392) with videos related to

Sort By:
Pageof 40
Cell Cycle (Georgetown, Tex.)|June 23, 2005
TELAML1-positive ALL: a discordant genotypeMonique L den Boer, William E Evans, Rob Pieters
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2006
Changes in hypercoagulability by asparaginase: a randomized study between two asparaginasesInge M Appel, Wim C J Hop, Rob Pieters
Seminars in Fetal & Neonatal Medicine|April 19, 2012
Diagnosis and management of neonatal leukaemiaMarieke H van der Linden, Sara Creemers, Rob Pieters
British Journal of Haematology|February 1, 2006
Towards targeted therapy for infant acute lymphoblastic leukaemiaRonald W Stam, Monique L den Boer, Rob Pieters
Pediatric Blood & Cancer|April 5, 2008
Perceived and actual motor competence of children treated for cancer with vincristine containing chemotherapyAnnelies Hartman, Rob Pieters, Cor van den Bos, et al.
Pediatric Blood & Cancer|September 24, 2015
Ammonia Levels Should Not Be Used as a Surrogate Marker of Levels of Asparaginase Activity in Acute Lymphoblastic Leukemia PatientsWing H Tong, Rob Pieters, Inge M van der Sluis
Pediatric Blood & Cancer|September 1, 2007
Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancerAnnelies Hartman, Cor van den Bos, Theo Stijnen, et al.
Cancer|February 3, 2006
Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristineAnnelies Hartman, Cor van den Bos, Theo Stijnen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic reviewLeiah J Brigitha, Rob Pieters, Inge M van der Sluis
Haematologica|June 3, 2016
HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?Jules Pp Meijerink, Kirsten Canté-Barrett, Eric Vroegindeweij, et al.
Pageof 40